The menopausal transition

Fertility and Sterility

Volumn 90, Issue 5 SUPPL., 2008, Pages

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN A; CIMICIFUGA RACEMOSA EXTRACT; CITALOPRAM; CLONIDINE; CONJUGATED ESTROGEN; DESVENLAFAXINE; ESTROGEN; FLUOXETINE; FOLLITROPIN; GABAPENTIN; GESTAGEN; INHIBIN A; INHIBIN B; LUTEINIZING HORMONE; MEDROXYPROGESTERONE ACETATE; MUELLERIAN INHIBITING FACTOR; MYELOPID; PAROXETINE; PLACEBO; REMIFEMIN MENOPAUSE; SERTRALINE; UNCLASSIFIED DRUG; VENLAFAXINE;

ARTICLE; COMBINATION CHEMOTHERAPY; ENDOCRINE FUNCTION; HORMONE DETERMINATION; HORMONE RELEASE; HOT FLUSH; HUMAN; INVOLUTIONAL DEPRESSION; MENOPAUSAL SYNDROME; PREMENSTRUAL DYSPHORIC DISORDER; PRIORITY JOURNAL; VASOMOTOR DISORDER;

ENDOCRINE SYSTEM; ENDOCRINE SYSTEM DISEASES; FEMALE; HORMONES; HOT FLASHES; HUMANS; MODELS, BIOLOGICAL; PERIMENOPAUSE;

EID: 55449112135     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2008.08.095     Document Type: Article

References (47)

1. Soules M.R., Sherman S., Parrott E., Rebar R., Santoro N., Utian W., et al. Executive summary: Stages of Reproductive Aging Workshop (STRAW). Fertil Steril 76 (2001) 874-878
2. McKinlay S.M., Brambilla D.J., and Posner J.G. The normal menopause transition. Maturitas 14 (1992) 103-115
3. Gracia C.R., Sammel M.D., Freeman E.W., Lin H., Langan E., Kapoor S., et al. Defining menopause status: creation of a new definition to identify the early changes of the menopausal transition. Menopause 12 (2005) 128-135
4. Randolph J.F., Crawford S., Dennerstein L., Cain K., Harlow S.D., et al. The value of follicle-stimulating hormone concentration and clinical findings as markers of the late menopausal transition. J Clin Endocrinol Metab 91 (2006) 3034-3040
5. Brambilla D.J., McKinlay S.M., and Johannes C.B. Defining the perimenopause for application in epidemiologic investigations. Am J Epidemiol 140 (1994) 1091-1095
6. Harlow S.D., Cain K., Crawford S., Dennerstein L., Little R., Mitchell E.S., et al. Evaluation of four proposed bleeding criteria for the onset of the late menopausal transition. J Clin Endocrinol Metab 91 (2006) 3432-3438
7. Wallace R.B., Sherman B.M., Bean J.A., Treloar A.E., and Schlabaugh L. Probability of menopause with increasing duration of amenorrhea in middle-aged women. Am J Obstet Gynecol 135 (1979) 1021-1024
8. McKinlay S.M., Bifano N.L., and McKinlay J.B. Smoking and age at menopause in women. Ann Intern Med 103 (1985) 350-356
9. Burger H.G., Dudley E.C., Hopper J.L., Groome N., Guthrie J.R., Green A., et al. Prospectively measured levels of serum follicle-stimulating hormone, estradiol, and the dimeric inhibins during the menopausal transition in a population-based cohort of women. J Clin Endocrinol Metab 84 (1999) 4025-4030
10. Randolph J.F., Sowers M., Gold E.B., Mohr B.A., Luborsky J., Santoro N., et al. Reproductive hormones in the early menopausal transition: relationship to ethnicity, body size, and menopausal status. J Clin Endocrinol Metab 88 (2003) 1516-1522
11. Santoro N., Lasley B., McConnell D., Allsworth J., Crawford S., Gold E.B., et al. Body size and ethnicity are associated with menstrual cycle alterations in women in the early menopausal transition: Study of Women's Health across the Nation (SWAN) Daily Hormone Study. J Clin Endocrinol Metab 89 (2004) 2622-2631
12. Klein N.A., Illingworth P.J., Groome N.P., McNeilly A.S., Battaglia D.E., and Soules M.R. Decreased inhibin B secretion is associated with the monotropic FSH rise in older, ovulatory women: a study of serum and follicular fluid levels of dimeric inhibin A and B in spontaneous menstrual cycles. J Clin Endocrinol Metab 81 (1996) 2742-2745
13. Santoro N., Isaac B., Neal-Perry G., Adel T., Weingart L., Nussbaum A., et al. Impaired folliculogenesis and ovulation in older reproductive aged women. J Clin Endocrinol Metab 88 (2003) 5502-5509
14. Shideler S.E., DeVane G.W., Kalra P.S., Benirschke K., and Lasley B.L. Ovarian-pituitary hormone interactions during the perimenopause. Maturitas 11 (1989) 331-339
15. Santoro N., Brown J.R., Adel T., and Skurnick J.H. Characterization of reproductive hormonal dynamics in the perimenopause. J Clin Endocrinol Metab 81 (1996) 1495-1501
16. Burger H.G., Dudley E.C., Hopper J.L., Shelley J.M., Green A., Smith A., et al. The endocrinology of the menopausal transition: a cross-sectional study of a population-based sample. J Clin Endocrinol Metab 80 (1995) 3537-3545
17. Hale G.E., Zhao X., Hughes C.L., Burger H.G., Robertson D.M., and Fraser I.S. Endocrine features of menstrual cycles in middle and late reproductive age and the menopausal transition classified according to the Staging of Reproductive Aging Workshop (STRAW) staging system. J Clin Endocrinol Metab 92 (2007) 3060-3067
18. Welt C.K., McNicholl D.J., Taylor A.E., and Hall J.E. Female reproductive aging is marked by decreased secretion of dimeric inhibin. J Clin Endocrinol Metab 84 (1999) 105-111
19. Reame N.E., Wyman T.L., Phillips D.J., de Kretser D.M., and Padmanabhan V. Net increase in stimulatory input resulting from a decrease in inhibin B and an increase in activin A may contribute in part to the rise in follicular phase follicle-stimulating hormone of aging cycling women. J Clin Endocrinol Metab 83 (1998) 3302-3307
20. Santoro N., Adel T., and Skurnick J.H. Decreased inhibin tone and increased activin A secretion characterize reproductive aging in women. Fertil Steril 71 (1999) 658-662
21. Toner J.P. The significance of elevated FSH for reproductive function. Baillieres Clin Obstet Gynaecol 7 (1993) 283-295
22. Farquhar C.M., Lethaby A., Sowter M., Verry J., and Baranyai J. An evaluation of risk factors for endometrial hyperplasia in premenopausal women with abnormal menstrual bleeding. Am J Obstet Gynecol 181 (1999) 525-529
23. Lethaby A., Irvine G., and Cameron I. Cyclical progestogens for heavy menstrual bleeding. Cochrane Database Syst Rev 2 (2000) CD001016
24. Lethaby A.D., Cooke I., and Rees M. Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding. Cochrane Database Syst Rev 4 (2005) CD002126
25. Guthrie J.R., Dennerstein L., Hopper J.L., and Burger H.G. Hot flushes, menstrual status, and hormone levels in a population-based sample of midlife women. Obstet Gynecol 88 (1996) 437-442
26. Mitchell E.S., Woods N.F., and Mariella A. Three stages of the menopausal transition from the Seattle Midlife Women's Health Study: toward a more precise definition. Menopause 7 (2000) 334-349
27. Dennerstein L., Dudley E.C., Hopper J.L., Guthrie J.R., and Burger H.G. A prospective population-based study of menopausal symptoms. Obstet Gynecol 96 (2000) 351-358
28. Randolph Jr. J.F., Sowers M., Bondarenko I., Gold E.B., Greendale G.A., Bromberger J.T., et al. The relationship of longitudinal change in reproductive hormones and vasomotor symptoms during the menopausal transition. J Clin Endocrinol Metab 90 (2005) 6106-6112
29. Guthrie J.R., Dennerstein L., Taffe J.R., Lehert P., and Burger H.G. Hot flushes during the menopause transition: a longitudinal study in Australian-born women. Menopause 12 (2005) 460-467
30. Gold E.B., Colvin A., Avis N., Bromberger J., Greendale G.A., Powell L., et al. Longitudinal analysis of the association between vasomotor symptoms and race/ethnicity across the menopausal transition: study of women's health across the nation. Am J Public Health 96 (2006) 1226-1235
31. Bromberger J.T., Meyer P.M., Kravitz H.M., Sommer B., Cordal A., Powell L., et al. Psychological distress and natural menopause: a multiethnic community study. Am J Public Health 91 (2001) 1435-1442
32. Freeman E.W., Sammel M.D., Liu L., Gracia C.R., Nelson D.B., and Hollander L. Hormones and menopausal status as predictors of depression in women in transition to menopause. Arch Gen Psychiatry 61 (2004) 62-70
33. Freeman E.W., Sammel M.D., and Nelson D.B. Associations of hormones and menopausal status with depressed mood in women with no history of depression. Arch Gen Psychiatry 63 (2006) 375-382
34. Kravitz H.M., Ganz P.A., Bromberger J., Powell L.H., Sutton-Tyrrell K., and Meyer P.M. Sleep difficulty in women at midlife: a community survey of sleep and the menopausal transition. Menopause 10 (2003) 19-28
35. Woods N.F., and Mitchell E.S. Symptoms during the perimenopause: prevalence, severity, trajectory, and significance in women's lives. Am J Med 118 Suppl 12B (2005) 14-24
36. Van Voorhis B.J. Genitourinary symptoms in the menopausal transition. Am J Med 118 Suppl 12B (2005) 47-53
37. Grady D. Clinical practice. Management of menopausal symptoms. N Engl J Med 355 (2006) 2338-2347
38. Soares C.N., Almeida O.P., Joffe H., and Cohen L.S. Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: a double-blind, randomized, placebo-controlled trial. Arch Gen Psychiatry 58 (2001) 529-534
39. Farquhar C.M., Marjoribanks J., Lethaby A., Lamberts Q., and Suckling J.A. Cochrane HT Study Group. Long term hormone therapy for perimenopausal and postmenopausal women. Cochrane Database Syst Rev 3 (2005) CD004143
40. Practice Committee of the American Society for Reproductive Medicine. Estrogen and progestogen therapy in postmenopausal women. Fertil Steril (2008) in press
41. Ettinger B. Vasomotor symptom relief versus unwanted effects: role of estrogen dosage. Am J Med 118 Suppl 12B (2005) 74-78
42. Grodstein F., Manson J.E., and Stampfer M.J. Hormone therapy and coronary heart disease: the role of time since menopause and age at hormone initiation. J Womens Health (Larchmt) 15 (2006) 35-44
43. Rossouw J.E., Prentice R.L., Manson J.E., Wu L., Barad D., Barnabei V.M., et al. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA 297 (2007) 1465-1477
44. Manson J.E., Bassuk S.S., Harman S.M., Brinton E.A., Cedars M.I., Lobo R., et al. Postmenopausal hormone therapy: new questions and the case for new clinical trials. Menopause 13 (2006) 139-147
45. Newton K.M., Reed S.D., LaCroix A.Z., Grothaus L.C., Ehrlich K., and Guiltinan J. Treatment of vasomotor symptoms of menopause with black cohosh, multibotanicals, soy, hormone therapy, or placebo: a randomized trial. Ann Intern Med 145 (2006) 869-879
46. Rapkin A.J. Vasomotor symptoms in menopause: physiologic condition and central nervous system approaches to treatment. Am J Obstet Gynecol 196 (2007) 97-106
47. Nelson H.D., Vesco K.K., Haney E., Fu R., Nedrow A., Miller J., et al. Nonhormonal therapies for menopausal hot flashes: systematic review and meta-analysis. JAMA 295 (2006) 2057-2071